Physiomics Plc (LON:PYC – Get Free Report) fell 7.4% during mid-day trading on Monday . The stock traded as low as GBX 1.02 ($0.01) and last traded at GBX 1.02 ($0.01). 686,122 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 8,663,399 shares. The stock had previously closed at GBX 1.11 ($0.01).
Physiomics Stock Up 9.8 %
The stock has a market cap of £2.29 million, a PE ratio of -13.83 and a beta of 1.69. The stock’s fifty day moving average price is GBX 0.78 and its 200 day moving average price is GBX 0.72.
Insiders Place Their Bets
In related news, insider Peter Sargent bought 459,090 shares of the stock in a transaction on Thursday, November 7th. The shares were acquired at an average price of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,712.21). Corporate insiders own 4.18% of the company’s stock.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Read More
- Five stocks we like better than Physiomics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Most Effectively Use the MarketBeat Earnings Screener
- What Does the Future Hold for Eli Lilly?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
